ReviewDrug target insights

Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir.

Supphachoke Khemla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.